Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Lasofoxifene treatment of aromatase-resistant ER+ cancer

Lasofoxifene treatment of aromatase-resistant ER+ cancer

US Patent 12433866 · Granted Oct 7, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Lasofoxifene treatment of aromatase-resistant ER+cancer2024
Lasofoxifene treatment of aromatase-resistant ER+cancer2024
Modulators of resistant androgen receptor2023
Modulators of resistant androgen receptor2019
Modulators of resistant androgen receptor2017
Modulators of resistant androgen receptor2016
2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole and estrogen formulations2014
2-Phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol and estrogen formula2003
2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations2002
Combinations of statins and estrogenic agents2002
Neutron guide1999
Non-contacting electro-pneumatic servo for vibration isolation1989